CLS Holdings USA (XCNQ:CLSH) Cash-to-Debt : 0.08 (As of Feb. 2024)

View and export this data going back to 2019. Start your Free Trial

What is CLS Holdings USA Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. CLS Holdings USA's cash to debt ratio for the quarter that ended in Feb. 2024 was 0.08.

If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, CLS Holdings USA couldn't pay off its debt using the cash in hand for the quarter that ended in Feb. 2024.

The historical rank and industry rank for CLS Holdings USA's Cash-to-Debt or its related term are showing as below:

XCNQ:CLSH' s Cash-to-Debt Range Over the Past 10 Years
Min: 0 Med: 0.1 Max: No Debt
Current: 0.08

During the past 11 years, CLS Holdings USA's highest Cash to Debt Ratio was No Debt. The lowest was 0.00. And the median was 0.10.

XCNQ:CLSH's Cash-to-Debt is ranked worse than
87.23% of 1049 companies
in the Drug Manufacturers industry
Industry Median: 0.95 vs XCNQ:CLSH: 0.08

CLS Holdings USA Cash-to-Debt Historical Data

The historical data trend for CLS Holdings USA's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

CLS Holdings USA Cash-to-Debt Chart

CLS Holdings USA Annual Data

Trend

May14

May15

May16

May17

May18

May19

May20

May21

May22

May23

Cash-to-Debt

Get a 7-Day Free Trial

0.57

0.15

0.08

0.10

0.07

CLS Holdings USA Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
Cash-to-Debt	Get a 7-Day Free Trial															0.06	0.07	0.08	0.13	0.08

Competitive Comparison of CLS Holdings USA's Cash-to-Debt

For the Drug Manufacturers - Specialty & Generic subindustry, CLS Holdings USA's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CLS Holdings USA's Cash-to-Debt Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CLS Holdings USA's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where CLS Holdings USA's Cash-to-Debt falls into.

CLS Holdings USA Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

CLS Holdings USA's Cash to Debt Ratio for the fiscal year that ended in May. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	1.349	/	(8.414	+	10.18)
	=	0.07

CLS Holdings USA's Cash to Debt Ratio for the quarter that ended in Feb. 2024 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	0.944	/	(2.72	+	9.604)
	=	0.08

CLS Holdings USA (XCNQ:CLSH) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

CLS Holdings USA Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of CLS Holdings USA's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

CLS Holdings USA (XCNQ:CLSH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CLS Holdings USA Inc (XCNQ:CLSH) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

CLSH:USA

Address

1800 Industrial Road, Suite 100, Las Vegas, NV, USA, 89102

Website

https://www.clsholdingsinc.com

CLS Holdings USA Inc is a diversified cannabis company that acts as an integrated cannabis producer and retailer through its Oasis Cannabis subsidiaries in Nevada and plans to expand to other states. CLS stands for Cannabis Life Sciences in recognition of the company's patented proprietary method of extracting various cannabinoids from the marijuana plant and converting them into products with a higher level of quality and consistency. The company's business model includes licensing operations, processing operations, processing facilities, sale of products, brand creation and consulting services. The company generates the majority of its revenues and corresponding accounts receivable from the sale of cannabis, and cannabis related products.